The HPV vaccine protects against several cancers linked to HPV strains and is fully covered by insurance since its introduction in 2006.
2
HPV-related cancers have increased significantly, with over 49,000 cases reported in the U.S. between 2018 and 2022, despite a decrease in cervical cancer rates.
3
Racial disparities persist in cervical cancer incidence and mortality, with Black women facing the highest mortality rates despite higher screening rates.
4
Gardasil®9 is the only HPV vaccine available in the U.S., protecting against nine HPV strains and approved for individuals aged 9 to 45.
5
The ACIP recommends a two-dose HPV vaccine series for adolescents to maximize effectiveness before sexual activity begins.